Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026)
Travere Therapeutics (TVTX) reported Prepaid Assets of $34.3 million for Q1 2026, up 152.25% on a YoY basis from $13.6 million in Q1 2025, and up 19.43% quarter-over-quarter from $28.8 million in Q4 2025.
Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026) Analysis & Trends
Travere Therapeutics has reported Prepaid Assets for 14 years, with the latest figure at $34.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 152.25% year-over-year to $34.3 million; the trailing twelve-month figure through Mar 2026 stood at $34.3 million (up 152.25% YoY), and the FY2025 full-year result was $28.8 million, up 126.72% from the prior year.
- Prepaid Assets for Q1 2026 stood at $34.3 million, up from $28.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $34.3 million in Q1 2026, with the low at $6.5 million in Q1 2022.
- Historically, Prepaid Assets has averaged $16.2 million across 5 years, with a median of $13.6 million in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 34.39% — and 2026, when it jumped 152.25%.
- Travere Therapeutics' Prepaid Assets stood at $12.0 million in 2022, then jumped by 60.68% to $19.3 million in 2023, then tumbled by 34.39% to $12.7 million in 2024, then soared by 126.72% to $28.8 million in 2025, then climbed by 19.43% to $34.3 million in 2026.
- The last three Prepaid Assets figures came in at $34.3 million (Q1 2026), $28.8 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Travere Therapeutics | 5.07 Bn | 4.99 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.35 Mn |
| Dec 31, 2025 | 28.76 Mn |
| Sep 30, 2025 | 28.05 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 13.62 Mn |
| Dec 31, 2024 | 12.69 Mn |
| Sep 30, 2024 | 15.78 Mn |
| Jun 30, 2024 | 13.14 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Dec 31, 2023 | 19.34 Mn |
| Sep 30, 2023 | 16.24 Mn |
| Jun 30, 2023 | 11.56 Mn |
| Mar 31, 2023 | 15.14 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 8.55 Mn |
| Jun 30, 2022 | 9.28 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | 6.72 Mn |
| Sep 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 7.34 Mn |